Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
Next >
CNBC Daily Open: October’s gravity bringing stocks down
October 04, 2024
Tickers
JOBS
OIL
Tags
World Markets
China Markets
Jobs
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
October 03, 2024
Tags
Diamondback Energy Inc
Valero Energy Corp
Tencent Holdings Ltd
From
CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
October 01, 2024
Tags
Eli Lilly and Co
U/S/ Economy
Marine Ports and Services
From
CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
October 01, 2024
Tags
Labor issues
Shipping
Walmart Inc
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
Tags
Eli Lilly and Co
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
5 things to know before the stock market opens Wednesday
September 25, 2024
Tags
Business News
Investing
Economy
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Social issues
GSK plc
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
September 24, 2024
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
September 23, 2024
Tags
KB Home
Constellation Energy Corp
Vistra Corp
From
CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
September 22, 2024
Tickers
NEWS
NVO
Tags
Benzinga
Zain Rizvi
General
From
Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
Tags
Health & Science
Breaking News: Business
Business News
From
CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
Tags
Roche Holding AG
Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Roche Holding AG
Healthy Returns
Eli Lilly and Co
From
CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
September 16, 2024
Tags
Retail
Amazon/com Inc
Economic events
From
CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
September 12, 2024
Tickers
JOBS
Tags
Daily Open
Bitcoin
Asia Markets
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Business
Pharmaceuticals
Companies
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Social issues
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Abbott Laboratories
Berkshire Hathaway Inc
Social issues
From
CNBC.com News
5 things to know before the stock market opens Tuesday
September 03, 2024
Tags
Politics
Economy
Markets
From
CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
September 02, 2024
Tags
Breaking News: Markets
Eli Lilly and Co
Pharmaceuticals
From
CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
August 27, 2024
Tags
Business
Pharmaceuticals
Companies
From
CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
August 21, 2024
Tags
Health care industry
Technology
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Politics
Bristol/Myers Squibb Co
Biotech and Pharmaceuticals
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Companies
Biotechnology
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Health & Science
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Eli Lilly and Co
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Eli Lilly and Co
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Health care industry
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Altimmune Inc
Healthy Returns
Viking Therapeutics Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.